Providers' attitude toward vaccinating young males against HPV may challenge new recommendations

March 13, 2012 in Cancer

Researchers from Boston University School of Medicine (BUSM) have found that a health care provider's attitude toward male human papillomavirus (HPV) vaccination may influence the implementation of new guidelines. They believe targeted provider education on the benefits of HPV vaccination for male patients, specifically the association of HPV with certain cancers in men, may be important for achieving vaccination goals. These findings appear on-line in the American Journal of Men's Health.

HPV infects approximately 20 million men and women in the United States each year. It can cause anal, penile and oropharyngeal cancers in men. Approximately 7,000 HPV-associated cancers are diagnosed in men annually. Last year, the Advisory Committee on Immunization Practices issued a revised statement recommending universal vaccination of 11- to 12-year-old males with catch-up vaccinations for males age13 to 21. The revised, stronger recommendation came in response to new data showing that vaccination could effectively prevent both and anal cancer precursors and epidemiologic data showing the increasing importance of HPV as a causal factor for head and neck cancers.

Between 2009 and 2010 BUSM researchers assessed pediatric and family medicine providers' attitudes and behaviors around HPV vaccinations. The providers included 23 physicians and eight from four community health centers in the Boston area that serve primarily low-income, minority and non-English-speaking populations. Although 24 of 31 (77 percent) of the providers favored vaccinating males, only three (12 percent) offered vaccination. Providers who did not offer vaccination felt that parents would not be interested in vaccinating sons to prevent in women and were largely unaware of serious HPV-related disease in males.

"Although we believe the new recommendations will likely cause some improvement in HPV vaccination levels for males, their adoption may remain slow if physicians are unaware of the rationale behind the strengthened recommendations," explained lead author Rebecca B. Perkins, MD, MSc., assistant professor of Obstetrics and Gynecology at BUSM.

According to Perkins, in light of the new recommendations promoting universal HPV vaccination for males, understanding provider attitudes and actions with regard to this vaccine gains increasing importance. "Although prior research indicated that most physicians supported HPV vaccination for males, research with both parents and providers raised concerns that parents may be more reluctant to vaccinate sons than daughters," she added.

Provided by Boston University Medical Center

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

New method for predicting cancer virulence developed

A new way of tackling cancer and predicting tumor virulence are has been reported by a French team of scientists from the Institut Albert Bonniot de Grenoble including researchers from CNRS, Inserm and Université Joseph ...

Cancer created 5 hours ago | popularity 5 / 5 (1) | comments 0

As summer approaches, experts offer tips on preventing skin cancer

(HealthDay)—Memorial Day weekend is the unofficial start of summer, and experts note that you need to protect your skin while spending time in the sun.

Cancer created 9 hours ago | popularity 5 / 5 (1) | comments 0

New fluorescent tools for cancer diagnosis

In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...

Cancer created May 24, 2013 | popularity 5 / 5 (1) | comments 0

Modulating the immune system to combat metastatic cancer

Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...

Cancer created May 24, 2013 | popularity 5 / 5 (2) | comments 0

Scientists put bowel cancer under the microscope

Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.

Cancer created May 24, 2013 | popularity 5 / 5 (1) | comments 0


'Should I stay or should I go?' Neuroscientists link brain cell types to behavior

Neuroscientists from Cold Spring Harbor Laboratory, led by Assistant Professor Adam Kepecs, have linked the activity of two types of brain nerve cells, neurons, to decisions made during particular type of ...

Study identifies genetic suspects in sporadic Lou Gehrig's disease

Researchers at the Stanford University School of Medicine have identified mutations in several new genes that might be associated with the development of spontaneously occurring cases of the neurodegenerative disease known ...

Scientists discover the origin of a giant synapse

Humans and most mammals can determine the spatial origin of sounds with remarkable acuity. We use this ability all the time—crossing the street; locating an invisible ringing cell phone in a cluttered bedroom. ...

Lawn mower injuries often caused by distraction

(HealthDay)—Each summer, lawn mower accidents send countless numbers of people to the emergency room. Mishaps often involve serious injuries to the fingers, hands and feet. Often caused by a moment's distraction, ...

Elderly woman dies of SARS-like virus in Saudi

An 81-year-old woman who had contracted a SARS-like coronavirus has died in Saudi Arabia, raising the death toll in the kingdom to 18, the health ministry said in a statement on Sunday.

RELAX-AHF shows first positive findings in HFpEF patients

Serelaxin may be more effective for relieving dyspnea in heart failure with preserved ejection fraction (HFpEF) than reduced (HFrEF) during the first 24 hours, according to results from RELAX-AHF presented in today's late ...